Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for dose response relationship, immunologic
Most Correlated Studies
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Fibrocystic disease of breast MCF10A cells treated with ligand perturbagens
- L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens
- Skin biospies from atopic dermatitis patients treated with apremilast
- L1000 CMAP - Acute promyelocytic leukemia HL60 cells treated with ligand perturbagens
Most Relevant Literature
- The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer…
- Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and …
- Can we define a tolerable level of risk in food allergy? Report from a EuroPrevall/UK Food Standards…
- Safety of allergen immunotherapy: a review of premedication and dose adjustment.
- The effect of passive immunization against ghrelin on feed and water intake in turkeys.
Most Relevant Clinical Trials
- A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy
- Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity
- Immunologic Profile of Peritoneal Cancer
- (VIII): The Eight Study and Immunologic Response Sub-study
- Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected…
